Modeling robust QSAR

Journal of Chemical Information and Modeling

Volumn 46, Issue 6, 2006, Pages 2310-2318

  Polanski, Jaroslaw ^a   Bak, Andrzej ^a   Gieleciak, Rafal ^a   Magdziarz, Tomasz ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ACQUISITION; ITERATIVE METHODS; MOLECULAR STRUCTURE; OPTIMIZATION; RISK ASSESSMENT; SAMPLING;

BIOLOGICAL SYSTEMS; CHEMICAL MOLECULES; MOLECULAR DESIGN; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR);

MOLECULAR DYNAMICS;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFORMATION; FACTUAL DATABASE; METHODOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; STATISTICS; THEORETICAL MODEL;

ALGORITHMS; CHEMISTRY; COMPUTER SIMULATION; DATABASES, FACTUAL; MODELS, CHEMICAL; MODELS, MOLECULAR; MODELS, STATISTICAL; MODELS, THEORETICAL; MOLECULAR CONFORMATION; NEURAL NETWORKS (COMPUTER); QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE; STOCHASTIC PROCESSES;

EID: 33845768010     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050314b     Document Type: Article

References (89)

1. Kolb, H.; Finn, G.; Sharpless, B. Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem., Int. Ed. 2001, 40, 2004-2021.
2. Mullin, R. Recalibrating the clinic. High-tech tools and streamlined business processes are making their way to the far reaches of the drug development pipeline. C&EN 2005, 83, 29-39.
3. De Julian-Ortiz, J. Virtual Darwinian drug design: QSAR inverse problem. Comb. Chem. High Throughput Screening 2000, 4, 295-310.
4. Hansch, C.; Leo, A. Exploring QSAR: Fundamentals and applications in chemistry and biology; American Chemical Society: Washington, DC, 1995.
5. Cox, H.; Heaney, K. Approaches to robustness, J. Acoust. Soc. Am. 2003, 113, 2262-2262.
6. Lipinski, A. Drug-like properties and the cause of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 2004, 44, 235-249.
7. Hann, M.; Oprea, T. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 2004, 8, 255-263.
8. Oprea, T. Current trends in lead discovery. Are we looking for the appropriate properties? J. Comput.-Aided Mol. Des. 2002, 16, 325-334.
9. Hansch, C.; Hoekman, D.; Leo, A.; Weininger, D.; Selassie, C. Chembioinformatics: Comparative QSAR at the interface between chemistry and biology. Chem. Rev. 2002, 102, 783-812.
10. Hodgson, J. ADMET - turning chemicals into drugs. Nat. Biotechnol. 2001, 19, 722-726.
11. Oprea, T. 3D-QSAR modeling in drug design. In Computational Medicinal Chemistry and Drug Discovery; Tolleneare, J., De Winter, H.; Langenaeker; W., Bultinck, P., Eds.; Marcel Dekker: New York, 2004.
12. Kubinyi, H. Quantitative structure-activity relationships. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character. J. Med. Chem. 1977, 20, 625-629.
13. Anzali, S.; Gasteiger, J.; Holzgrabe, U.; Polanski, J.; Sadowski, J.; Teckentrup, A.; Wagener, M. The use of self-organizing neural networks in drug design. Kubinyi, H., Folkers, G., Martin, Y., Eds.; Kluwer: Dordrecht, The Netherlands, 1998.
14. Xu, L.; Zhang, W. Comparison of different methods for variable selection, Anal. Chim. Acta 2001, 446, 477-483.
15. Leardi, R. Genetic algorithms in chemometrics and chemistry: A review. J. Chemom. 2001, 15, 559-569.
16. Saxena, K.; Prathipati, P. Comparison of MLR, PLS and GA-MLR in QSAR. SAR QSAR Environ. Res. 2003, 14, 433-445.
17. Vapnik, V. N. The nature of statistical learning theory; Verlag Springer: New York, 1999.
18. Furey, T.; Cristianini, N.; Duffy, N.; Bednarski, D.; Schummer, M.; Haussler, D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000, 16, 906-914.
19. Norinder, U. Support vector machine models in drug design: application to drug transport processes and QSAR using simplex optimizations and variable selection. Neurocompiuting 2003, 55, 337-346.
20. Demiriz, A.; Bennet, K.; Breneman, C.; Embrechts, M. Support vector machine regression in chemometrics. Comput. Sci. Stat. 2001, 33, 289-296.
21. Corne, D. W.; Martin A. C. Artificial intelligence in bioinformatics. Comput. Chem. 2002, 26, 1-3.
22. David, V.; Sanchez, A. Advanced support vector machine and kernel methods. Neurocomputing 2003, 55, 5-20.
23. Burbidge, R.; Trotter, M.; Buxton, B. Drug design by machine learning: support vector machines for pharmaceutical data analysis. Comput. Chem. 2001, 26, 5-14.
24. Varmuza, K. Multivariate data analysis in chemistry. In Handbook of chemoinformatics; Wiley VCH: Verlag: Weinheim, 2003.
25. Esbensen, S.; Geladi, P. Principal component analysis. Chemom. Intell. Lab. Syst. 1987, 2, 37-52.
26. Geladi, P.; Kowalski, B. Partial least squares: A tutorial. Anal. Chim. Acta 1986, 185, 1-17.
27. Helland, I. Some theoretical aspects of partial least squares regression. Chemom. Intell. Lab. Syst. 2001, 58, 97-107.
28. Good, P. Resampling methods: A practical guide to data analysis; Birkhauser: 1999.
29. Wold, S.; Sjöström, M.; Eriksson, L. In The Encyclopedia of Computational Chemistry; Wiley and Sons: Chichester, U.K., 1999.
30. Wakeling, N.; Morris, J. A test of significance for partial squares regression. J. Chemom. 1993, 7, 291-304.
31. Clark, M.; Crammer III, R. The probability of chance correlation using partial least squares (PLS). Quant. Struct. - Act. Relat. 1993, 12, 137-145.
32. Tropsha, A.; Gramatica, P.; Gombar, K. The importance on being earnest: Validation is the absolute essential for successful application and interpretation of QSAR models. QSAR 2003, 22, 69-77.
33. 2! J. Mol. Graphics Modell. 2002, 20, 269-276.
34. Daweyko, A. 3D-QSAR illusions. J. Comput.-Aided Mol. Des. 2004, 18, 587-596.
35. Polanski, J.; Gieleciak, R.; Bak, A. Probability issues in molecular design: Predictive and modeling ability in 3D-QSAR schemes. Comb. Chem. High Throughput Screening 2004, 7, 793-807.
36. Clark, R. Boosted leave-many-out cross-validation: The effect of training and test set diversity on PLS statistics. J. Comput.-Aided Mol. Des. 2003, 17, 265-275.
37. Sheridan, R.; Feuston, B.; Maiorov, V.; Kearsley, S. Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR. J. Chem. Inf. Comput. Sci. 2004, 44, 1912-1928.
38. Cramer III, R.; Patterson, D.; Bunce, J. Comparative molecular field analysis (CoMFA). J. Am. Chem. Soc. 1998, 110, 5959-5967.
39. Kubinyi, H. Comparative molecular field analysis (CoMFA). In Handbook of Chemoinformatics. From data to knowledge; Gasteiger. J., Ed.; Wiley VCH: BRD, Weinheim, 2003.
40. Melani, F.; Gratteri, P.; Adamo, M.; Bonaccini, C. Field interaction and geometrical overlap: A new simplex and experimental design based computational procedure for superposing small ligand molecules. J. Med. Chem. 2003, 46, 1359-1371.
41. Lemmen, C.; Lengauer, T. Computational methods for the structural alignment of molecules. J. Comput.-Aided Mol. Des. 2000, 14, 215-232.
42. Wagener, M.; Sadowski, J.; Gasteiger, J. Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. 1995, 117, 7769-7775.
43. Zupan, J.; Gasteiger, J, Neural Networks in Chemistry and Drug Design, 2nd ed.; Wiley VCH: BRD, Weinheim, 1999.
44. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4136.
45. Polanski, J. The receptor like neural network for modeling corticosteroid and testosterone binding globulins. J. Chem. Inf. Comput. Sci. 1997, 37, 553-561.
46. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. GRID-independent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. J. Med. Chem. 2000, 43, 3233-3243.
47. Silverman, B.; Platt, D. Comparative molecular field moment analysis (CoMMA). J. Med. Chem. 1996, 39, 2129-2140.
48. Free, S.; Wilson, J. A mathematical contribution to structure -activity studies. J. Med. Chem. 1964, 7, 395-399.
49. Korhonen, S. P.; Tuppurainen, K.; Laatikainen, R.; Peräkyla, M. FLUFF-BALL A template-based grid-independent superposition and QSAR technique: Validation using a benchmark steroid data set. J. Chem. Inf. Comput. Sci. 2003, 43, 1780-1793.
50. Jain, A,; Koile, K.; Champan, D. Compass: Predicting biological activities from molecular surface properties. Performance comparison on a steroid benchmark. J. Med. Chem. 1994, 37, 2315-2327.
51. Polanski, J.; Walczak, B. The comparative molecular surface analysis (CoMSA): A novel tool for molecular design. Comput. Chem. 2000, 24, 615-625.
52. Polanski, J.; Gieleciak, R.; Magdziarz, T.; Bak, A. The grid formalism for the comparative molecular surface analysis: Application to the CoMFA benchmark steroids, azo dyes and HEPT derivatives. J. Chem. Inf. Comput. Sci. 2004, 44, 1423-1435.
53. Polanski, J.; Bak, A.; Gieleciak, R.; Magdziarz, T. Self-organizing neural network for modeling robust 3D and 4D QSAR: Application to dihydrofolate reductase inhibitors. Molecules 2004, 9, 1148-1159.
54. Polanski, J. Molecular Shape Analysis. In Handbook of Chemoinformatics. From data to knowledge; Gasteiger, J., Ed.; Wiley VCH: BRD, Weinheim, 2003.
55. Kohonen, T. Self-organizing and associate memory, 3rd ed.; Springer; Berlin, 1989.
56. Gasteiger, J.; Li, X.; Rudolph, C.; Sadowski, J.; Zupan, J. Representation of molecular electrostatic potentials by topological feature maps. J. Am. Chem. Soc. 1994, 116, 4608-4620.
57. Gasteiger, J.; Zupan, J. Neural networks in chemistry. Angew. Chem., Int. Ed. Engl. 1993, 32, 503-512.
58. Polanski, J.; Gasteiger, J.; Wagener, M.; Sadowski, J. The comparison of molecular surfaces by neural networks and its application to quantitative structure activity studies. Quant. Struct.-Act. Relat. 1998, 17, 27-36.
59. Anzali, S.; Barnickel, G.; Krug, M.; Sadowski, J.; Wagener, M.; Gasteiger, J.; Polanski, J. The comparison of geometric and electronic properties of molecular surfaces by neural networks: Applications to the analysis of corticosteroid binding globulin activity of steroids. J. Comput-Aided Mol. Des. 1996, 10, 521-534.
60. Anzali, S.; Maderski, W.; Osswald, M.; Dorsch, D., Endothelin antagonists: Search for surrogates of methylendioxyphenyl by means of a Kohonen neural network. Bioorg. Med. Chem. Lett. 1998, 8, 11-16.
61. Polanski, J.; Gasteiger, J.; Jarzembek, K. Self-organizing neural networks for screening and development of novel artificial sweetener candidates. Comb. Chem. High Throughput Screening 2000, 3, 481-495.
62. Barlow, T. Self-organizing maps and molecular similarity. J. Mol. Graphics 1995, 13, 24-27.
63. Polanski, I.; Gasteiger, J. The comparison of molecular surface by assembly of self-organizing neural network, In proceedings of the IIIth International Conference "Computers in Chemistry '94", Technical University of Wroclaw, Wroclaw, Poland, 1994, p 88.
64. Livingstone, D.; Manallack, D. Neural networks in 3D QSAR. QSAR Comb. Sci. 2003, 22, 510-518.
65. Polanski, J.; Gieleciak, R.; Bak, A.; Jarzembek, K.; Wyszomirski, M. The comparative molecular surface analysis (CoMSA). A novel efficient technique for drug design. Acta Pol. Pharm. 2002, 59, 459-461.
66. a values of benzoic and alkanoic acids. J. Chem. Inf. Comput. Sci. 2002, 42, 184-191.
67. Hasegawa, K.; Morikami, K.; Shiratori, Y.; Ohtsuka, T.; Aoki, Y.; Shimma, N. 3D-QSAR study of antifungal N-myristoyltra transferase inhibitors by comparative molecular surface analysis. Chemom. Intell. Lab. Syst. 2003, 69, 51-59.
68. Hasegawa, K.; Matsuoka, S.; Arakawa, M.; Funatsu, K. New molecular surface-based 3D-QSAR metod using Kohonen neural network and 3-way PLS. Comput. Chem. 2002, 26, 583-589.
69. Wermuth, C. The impact of QSAR and CADD methods in drug discovery In Rational approach to drug design; Höltji, H., Sippl, W., Eds.; Prous Science: Barcelona, 2001.
70. 2-guided region selection for comparative molecular field analysis: A simple method to achieve consistent results. J. Med. Chem. 1995, 38, 1060-1066.
71. 2-GRS approach. J. Med. Chem. 1996, 39, 1383-1395.
72. Polanski, J.; Gieleciak, R. The comparative molecular surface analysis (CoMSA) with modified uninformative variable elimination PLS (UVE-PLS) method: Application to the steroids binding the aromatase enzyme. J. Chem. Inf. Comput. Sci. 2003, 43, 656-666.
73. Polanski, J. Self-organizing neural networks for pharmacophore mapping. Adv. Drug Deliv. Rev. 2003, 55, 1149-1162.
74. Gieleciak, R.; Magdziarz, T.; Bak, A.; Polanski, J. Modeling robust QSAR 1: Coding molecules in 3D QSAR - from a point to surface sectors and molecular volumes. J. Chem. Inf. Model. 2005, 45, 1447-1455.
75. Hopfinger, A.; Wang, S.; Tokarski, J.; Jin, B.; Albuquerque, M.; Madhav, P.; Duraiswami, C. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Chem. Soc. 1997, 119, 10509-10524.
76. 2 receptor antagonists. J. Chem. Inf. Comput. Sci. 1998, 38, 925-938.
77. Santos-Filho, O.; Hopfinger, A. A search for sources of drug resistance by the 4D-QSAR analysis of a set of antimalarial dihydrofolate reductase inhibitors. J. Comput-Aided Mol. Des. 2001, 15, 1-12.
78. Ravi, M.; Hopfinger, A.; Hormann, R.; Dinan, L. 4D-QSAR analysis of a set of ecdysteroids and a comparison to CoMFA modeling. J. Chem. Inf. Comput. Sci. 2001, 41, 1587-1604.
79. A receptor. J. Med. Chem. 2002, 45, 3210-3221.
80. A receptor site using 4D-QSAR analysis. J. Chem. Inf. Comput. Sci. 2003, 43, 324-336.
81. a values and steroic CBG binding affinities. J. Chem. Inf. Comput. Sci. 2003, 43, 2081-2092.
82. Bak, A.; Polanski, J. The 4D-QSAR study on anti-HIV HEPT analogues. Bioorg. Med. Chem. 2006, 14, 273-279.
83. Kireev, D.; Chrétien, J.; Grierson, D.; Monneret, C. A 3D-QSAR study of a series of HEPT analogues: The influence of conformational mobility on HIV-1 reverse transcriptase inhibition. J. Med. Chem. 1997, 40, 4257-4264.
84. Jalali-Heravi, M.; Parastar, F. Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives. J. Chem. Inf. Comput. Sci. 2000, 40, 147-154.
85. Murcia, M.; Ortiz, A. Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors. J. Med. Chem. 2004, 47, 805-820.
86. Wang, T.; Wade, R. Comparative binding energy (COMBINE) analysis of OppA-peptide complexes to relate structure to binding thermodynamics. J. Med. Chem. 2002, 45, 4828-4837.
87. Rodriguez-Barrios, F.; Gago, F. Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles. J. Am. Chem. Soc. 2004, 126, 2718-2719.
88. Rondeau, J. M.; Schreuder, H. Protein Crystallography and Drug Discovery, In The Practice of Medicinal Chemistry; Wermuth, C. G., Ed.; Academic Press: 2003; pp 417-443.
89. Sippl, W.; Contreras, M.; Parrot, I.; Rival, M.; Wermuth, G. Structure-based 3D-QSAR and design of novel acetylcholinesterase inhibitors. J. Comput.-Aided Mol. Des. 2001, 15, 395-410.